NTRR NEUTRA CORP.
Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1512886 · Fiscal year ends 01/31
Financial factors as of 2023-10-31 (2024Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-82.7%
TTM net income YoY-2.5%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin46.2%
Operating margin-1,457.1%
Net margin-2,723.6%
FCF margin—
EBITDA margin-1,103.4%
Returns
ROE—
ROA-758.7%
ROIC (approx.)—
Asset turnover0.28x
Leverage & solvency
Liabilities / assets3,574.0%
Debt / equity—
Current ratio0.02x
Interest coverage-14.07x
Cash quality & payout
Operating cash flow / net income0.02x
Accruals ratio-743.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20232023-01-31 | FY20222022-01-31 |
|---|---|---|
| Income statement | ||
| Revenue | $67,996 | $92,014 |
| Cost of revenue | $32,690 | $60,853 |
| Gross profit | $35,306 | $31,161 |
| SG&A expense | $227,974 | $508,482 |
| Operating income | -$297,675 | -$583,582 |
| Interest expense | $62,063 | $60,606 |
| Pretax income | -$557,894 | -$632,926 |
| Income tax | $3,523 | — |
| Net income | -$561,417 | -$632,926 |
| EBITDA | -$218,769 | -$505,797 |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $1,969 | $1,056 |
| Inventory | $23,846 | — |
| Current assets | $25,815 | $2,666 |
| PP&E, net | $49,360 | $128,266 |
| Total assets | $75,175 | $130,932 |
| Current liabilities | $759,639 | $1.15M |
| Total liabilities | $813,795 | $1.15M |
| Shareholders' equity | -$773,820 | -$1.27M |
| Shares outstanding | 2.74B | 1.78B |
| Cash flow statement | ||
| Operating cash flow | -$153,243 | -$405,615 |
| Capital expenditure | — | $40,227 |
| Free cash flow | — | -$445,842 |
| Investing cash flow | — | -$40,227 |
| Financing cash flow | $154,156 | $423,590 |
| Depreciation & amortization | $78,906 | $77,785 |
Free plan shows the latest 2 periods; Pro shows all 12 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.